Ligand Pharmaceuticals Incorporated (LGND): Price and Financial Metrics

LGND POWR Grades

• LGND scores best on the Quality dimension, with a Quality rank ahead of 80.34% of US stocks.
• The strongest trend for LGND is in Stability, which has been heading up over the past 177 days.
• LGND ranks lowest in Momentum; there it ranks in the 7th percentile.

LGND Stock Summary

• With a year-over-year growth in debt of -91.93%, LIGAND PHARMACEUTICALS INC's debt growth rate surpasses just 1.29% of about US stocks.
• In terms of twelve month growth in earnings before interest and taxes, LIGAND PHARMACEUTICALS INC is reporting a growth rate of -3,708.44%; that's higher than just 0.36% of US stocks.
• As for revenue growth, note that LGND's revenue has grown -32% over the past 12 months; that beats the revenue growth of merely 8.2% of US companies in our set.
• Stocks that are quantitatively similar to LGND, based on their financial statements, market capitalization, and price volatility, are MAX, SII, BRDG, EXPI, and OWL.
• LGND's SEC filings can be seen here. And to visit LIGAND PHARMACEUTICALS INC's official web site, go to www.ligand.com.

LGND Valuation Summary

• LGND's price/sales ratio is 6.3; this is 231.58% higher than that of the median Healthcare stock.
• LGND's price/sales ratio has moved down 2 over the prior 243 months.

Below are key valuation metrics over time for LGND.

LGND Growth Metrics

Its year over year cash and equivalents growth rate is now at -52.93%.
• Its 4 year net cashflow from operations growth rate is now at -177.82%.
• The 2 year net income to common stockholders growth rate now stands at 138.66%.

LGND's revenue has moved down $654,000 over the prior 49 months.

The table below shows LGND's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	241.673	112.02	-21.292
2022-06-30	240.42	111.556	-7.973
2022-03-31	267.676	120.055	23.647
2021-12-31	277.133	78.798	57.138
2021-09-30	274.65	51.693	68.315
2021-06-30	251.663	44.413	47.891

LGND's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LGND has a Quality Grade of C, ranking ahead of 59.87% of graded US stocks.
• LGND's asset turnover comes in at 0.195 -- ranking 202nd of 681 Pharmaceutical Products stocks.
• NBIX, IRWD, and MNKD are the stocks whose asset turnover ratios are most correlated with LGND.

The table below shows LGND's key quality metrics over time.